Evaluating Quality Metrics for Risk-Based Surveillance of Drug Manufacturing Operations and Facilities (U01)

The goal of this project is to evaluate a set of potential quality metrics for their utility in monitoring quality across the pharmaceutical manufacturing sector.

This project aids to support FDA's efforts in transforming quality oversight from a qualitative to a quantitative and expertise-based

credit: sun-sentinel


assessment in order to assure that quality drugs are available to the American public.

The outcomes of the project could also be used to assist in the development of a risk-based inspection approach for domestic and foreign drug establishments.

Related Programs

Food and Drug Administration_Research

Department of Health and Human Services


Agency: Food and Drug Administration

Office:

Estimated Funding: $1,000,000


Relevant Nonprofit Program Categories





Obtain Full Opportunity Text:
Full Announcement of RFA-FD-16-004 on NIH Guide for Grants and Contracts

Additional Information of Eligibility:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Non-domestic (non-U.S.) components of U. S. Organizations are eligible to apply.

Foreign components, as defined in the HHS Grants Policy Statement, are allowed.



Full Opportunity Web Address:


Contact:


Agency Email Description:


Agency Email:
lisa.ko@fda.hhs.gov

Date Posted:
2015-07-31

Application Due Date:
2015-10-16

Archive Date:
2015-11-15


HootSuite CEO Ryan Holmes says “…social tools are getting more broadly adopted across organizations. It’s not just marketing anymore, it’s sales, public relations, human relations, everywhere.”






More Federal Domestic Assistance Programs


National Organizations of State and Local Officials | Measures and Analyses of the U.S. Economy | ECA Individual Grants | Business and International Education Projects | ARRA Health Information Technology Beacon Communities |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders